Investigation on Drugs for Asthma Control Administered by Pediatric Clinicians-Selection of Inhaled Corticosteroids and Compliance Evaluation of Patients
- VernacularTitle:儿科医师对哮喘控制类用药——吸入性糖皮质激素的用药选择及对患者用药依从性评价的调查
- Author:
Yuncui YU
1
;
Lulu JIA
1
;
Meng ZHANG
1
;
Xuan ZHANG
1
;
Yiwei LIU
2
;
Xiaoxia PENG
3
;
Li XIANG
4
;
Xiaoling WANG
1
Author Information
1. Clinical Research Center，Beijing Children’s Hospital，Capital Medical University/National Center for Children’s Health，Beijing 100045，China
2. School of Public Health，Keio University School of Medicine，Tokyo 160-8582，Japan
3. Center for Clinical Epidemiology and Evidence-based Medicine，Beijing Children’s Hospital，Capital Medical University/National Center for Children’s Health，Beijing 100045，China
4. Dept. of Allergy，Beijing Children’s Hospital，Capital Medical University/National Center for Children’s Health，Beijing 100045，China
- Publication Type:Journal Article
- Keywords:
Inhaled corticosteroids;
Budesonide;
Beclomethasone;
Fluticasone;
Compliance;
Pediatric asthma;
Pediatrician;
Investigation and study
- From:
China Pharmacy
2019;30(3):408-412
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE： To provide reference for the selection of inhaled corticosteroids （ICS） in clinic. METHODS： A questionnaire survey was conducted among pediatricians from medical institutions of 11 provinces （districts， cities） to analyze the drug selection and reasons， dosage form selection [by comprehensive score （CS）] of 3 kinds of ICS as budesonide （BUD）， beclomethasone （BDP） and fluticasone （FP）， medication compliance and influential factors （by CS）. RESULTS： A total of 200 questionnaires were sent out， and 196 valid questionnaires were collected with effective rate of 98.00％. Pediatric clinicians preferred BUD as a control drug for asthma in children （158 cases， 80.61％）， followed by FP （22 cases， 11.22％） and BDP （2 cases， 1.02％） and the rest had no tendency （14 cases， 7.14％）. Clinicians who chose BUD mainly believed that the drug had better clinical efficacy， and was more recommended by guidelines and experts， more recognized by patients and so on. In addition， of all inhalation equipment for children asthma， pediatric clinicians believed that parents or children were more easier to master atomizer （CS： 4.04）， followed by pressurized metered dose inhalers （pMDI） （with spacer） （CS： 2.75）， pMDI （without spacer） （CS： 1.71）， dry powder inhalers （DPI） （turbuhaler） （CS： 1.46） and DPI （accuhaler） （CS： 1.08）. For the evaluation of patients’ medication compliance， 48 （24.49％）， 88 （44.90％）， 58 （29.59％） pediatricians thought that the actual administration accounted for ＜50％， 50％-74％， 75％-99％ of the medical order dosages， respectively. Only 2 （1.02％） subjects thought that the patients would fully obey. The main factors affecting children’s medication compliance were worrying about side effects of long-term medication （CS： 9.19）， drug withdrawal after improvement （CS： 8.16）， and children’s treatment incompatibility （CS： 7.82）. CONCLUSIONS： Pediatricians tend to choose BUD as drug for asthma control， and atomizer is treated as the easiest inhalation equipment for children. At the same time， pediatricians have low evaluation on the medication compliance of parents and children.
